Cardax Inc (CDXI)
0.00
USD |
OTCM |
May 16, 16:00
Cardax Cash from Operations (TTM): -1.560M for March 31, 2021
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2021 | -1.560M |
| December 31, 2020 | -1.792M |
| September 30, 2020 | -1.882M |
| June 30, 2020 | -2.458M |
| March 31, 2020 | -2.887M |
| December 31, 2019 | -3.523M |
| September 30, 2019 | -3.536M |
| June 30, 2019 | -3.379M |
| March 31, 2019 | -3.466M |
| December 31, 2018 | -3.200M |
| September 30, 2018 | -3.395M |
| June 30, 2018 | -3.316M |
| March 31, 2018 | -2.676M |
| December 31, 2017 | -2.081M |
| September 30, 2017 | -1.796M |
| June 30, 2017 | -1.451M |
| March 31, 2017 | -1.351M |
| Date | Value |
|---|---|
| December 31, 2016 | -1.257M |
| September 30, 2016 | -1.294M |
| June 30, 2016 | -1.397M |
| March 31, 2016 | -1.480M |
| December 31, 2015 | -1.506M |
| September 30, 2015 | -1.847M |
| June 30, 2015 | -2.478M |
| March 31, 2015 | -3.236M |
| December 31, 2014 | -5.695M |
| September 30, 2014 | -4.922M |
| June 30, 2014 | -3.800M |
| March 31, 2014 | -2.746M |
| December 31, 2013 | -0.0188M |
| September 30, 2013 | -0.0247M |
| June 30, 2013 | -0.0288M |
| March 31, 2013 | -0.0289M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-3.536M
Minimum
Sep 2019
-1.560M
Maximum
Mar 2021
-2.627M
Average
-2.672M
Median
Cash from Operations (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.516M |
| Palatin Technologies Inc | -33.74M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -18.27M |
| Oragenics Inc | -7.291M |